Lagrangeville, NY, United States of America

James P Fandl

This inventor holds 68 USPTO granted patents and 18 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Antibody Engineering (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James P Fandl. Retrieved from https://idiyas.com/inventor/james-p-fandl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 68 (Patent Applications = 18)

% Patents Active = 92.6

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 14 (Patent Applications = 11)

Average Co-Inventor Count = 3.8

ph-index = 17

Forward Citations = 1,342(Granted Patents)

Forward Citations (Not Self Cited) = 1,206(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

67 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

1 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 1995-2026

Loading Chart...

Areas of Expertise:

High Affinity Antibodies

CHO Integration Sites

Recombinant Proteins

Fucosylation-Deficient Cells

Inducible Eukaryotic Expression System

Fusion Polypeptides

Expression-Enhancing Loci

Secreted Proteins

Antibody Compositions

Nucleic Acids

Stability Regions

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577326 - Recombinant Cell Surface Capture Proteins (2026-03-17),

2. 12565667 - CHO INTEGRATION SITES AND USES THEREOF (2026-03-03),

3. 12528883 - COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF EXPRESSION-ENHANCING LOCI (2026-01-20),

4. 12503520 - COMPOSITIONS AND METHODS FOR MAKING ANTIBODIES BASED ON USE OF AN EXPRESSION-ENHANCING LOCUS (2025-12-23),

5. 12480947 - Method for generating high affinity antibodies (2025-11-25),

6. 12054751 - Fucosylation-deficient cells (2024-08-06),

7. 11808766 - Method for generating high affinity antibodies (2023-11-07),

8. 11788102 - CHO integration sites and uses thereof (2023-10-17),

9. 11560550 - Fucosylation-deficient cells (2023-01-24),

10. 11530277 - Compositions and methods for making antibodies based on use of an expression-enhancing locus (2022-12-20),

11. 11512144 - Compositions and methods for making antibodies based on use of an expression-enhancing loci (2022-11-29),

12. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),

13. 11268109 - CHO integration sites and uses thereof (2022-03-08),

14. 11085053 - Efficient selectivity of recombinant proteins (2021-08-10),

15. 10752698 - Method for generating high affinity antibodies (2020-08-25),

Title: James P Fandl - Innovative Inventor from Lagrangeville, NY

Introduction: James P Fandl is a renowned inventor hailing from Lagrangeville, NY, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: James P Fandl holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, James P Fandl has worked tirelessly to bring his innovative ideas to life, revolutionizing industries and pushing the boundaries of what is possible.

Collaborations: Throughout his career, James P Fandl has collaborated with leading tech companies, research institutions, and universities to further develop and refine his inventions, demonstrating his commitment to excellence and advancement in the field.

Conclusion: James P Fandl's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor, inspiring the next generation of innovators to push the limits of what is achievable.

Profile summary based on public USPTO records.